AbbVie, a global biopharmaceutical company based in Illinois, is leveraging AI and NLP from Intel to enable the discovery of new treatments for patients.
AbbVie, a global biopharmaceutical company based in Illinois, is leveraging Artificial Intelligence (AI) and Natural Language Processing (NLP) for research translation, improving collaboration and search capabilities to enable the discovery of new treatments for patients.
With 47,000 employees around the world, AbbVie serves more than 30 million patients in 175 countries. With a geographically diverse team collaborating on numerous projects at the same time, AbbVie’s researchers need to be able to access critical data in a variety of languages.
The enterprise found commercially available language translation services failed to provide the most accurate translations for their highly domain-specific biomedical text, making it difficult to collaborate and ensure access to the latest research – a challenge felt across the research industry by researchers who speak English as a second language. To solve this problem, AbbVie created its own domain-specific translation and search tools, leveraging AI.
Brian Martin, Head of Artificial Intelligence at AbbVie, said: “We built Abbelfish Machine Translation and AbbVie Search to accelerate and scale the work of our researchers, reducing the time it takes to discover and deliver transformative medicines and therapies for patients. We’re looking to leverage Intel technology in a new way to deploy these capabilities at scale across the enterprise.”
Abbelfish Machine Translation is a language translation service originally designed for German to English translation, which has expanded to include Spanish, Italian, French, Portuguese, Russian, Chinese and Japanese. Over one million texts are translated each year with the Abbelfish service, using up to 10 concurrent translations per minute.
AbbVie Search is a question and answer-based search tool for biomedical researchers, based on the BioBERT transformer model. AbbVie Search allows a researcher to ask a question, such as ‘What is the most common species of human Coronavirus among adults?’ with the system quickly responding with the answer, ‘HCoV-OC43’ including a collection of relevant scientific articles and clinical notes.
AbbVie leveraged Intel technology to speed up inference for Abbelfish Machine Translation and AbbVie Search. With 2nd Gen Intel Xeon Scalable processors and the Intel Optimization for TensorFlow with Intel oneAPI Deep Neural Network Library, AbbView sped up Abbelfish by 1.9x. By leveraging 2nd Gen Intel Xeon and the Intel OpenVINO toolkit, AbbVie Search was accelerated by 5.3X.
Click below to share this article